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ABSTRACT
Microglia express multiple TLRs (Toll-like receptors) and
provide important host defence against viruses that invade
the CNS (central nervous system). Although prior studies
show these cells become activated during experimental
alphavirus encephalitis in mice to generate cytokines and
chemokines that influence virus replication, tissue inflam-
mation and neuronal survival, the specific PRRs (pattern
recognition receptors) and signalling intermediates con-
trolling microglial activation in this setting remain
unknown. To investigate these questions directly in vivo,
mice ablated of specific TLR signalling molecules were
challenged with NSV (neuroadapted Sindbis virus) and CNS
viral titres, inflammatory responses and clinical outcomes
followed over time. To approach this problem specifically
in microglia, the effects of NSV on primary cells derived
from the brains of wild-type and mutant animals were
characterized in vitro. From the standpoint of the virus,
microglial activation required viral uncoating and an intact
viral genome; inactivated virus particles did not elicit
measurable microglial responses. At the level of the target
cell, NSV triggered multiple PRRs in microglia to produce a
broad range of inflammatory mediators via non-overlap-
ping signalling pathways. In vivo, disease survival was
surprisingly independent of TLR-driven responses, but still
required production of type-I IFN (interferon) to control
CNS virus replication. Interestingly, the ER (endoplasmic
reticulum) protein UNC93b1 facilitated host survival
independent of its known effects on endosomal TLR
signalling. Taken together, these data show that alpha-
viruses activate microglia via multiple PRRs, highlighting
the complexity of the signalling networks by which CNS
host responses are elicited by these infections.
Key words: encephalitis, microglia, Sindbis virus, Toll-like
receptors, type-I interferon, UNC93b1.
INTRODUCTION
TLRs (Toll-like receptors) are widely expressed innate immune
sensors that evolved to recognize specific PAMPs (pathogen-
associated molecular patterns) (Janeway and Medzhitov, 2002;
Takeda et al., 2003). Within the TLR family, TLR3, TLR7, TLR8
and TLR9 are nucleotide-sensing receptors located in various
intracellular compartments, including the ER (endoplasmic
reticulum), endosomes and lysosomes (Saitoh and Miyake,
2009). These receptors detect common replication intermedi-
ates of most viral pathogens, including double-stranded RNA
(TLR3),single-stranded RNA(TLR7 and TLR8) and unmethylated
DNA (TLR9). Along with TLR2 and TLR4 that can respond to
certainviralproteins, thesereceptorsform a criticalnetworkof
sensors that activate innate host responses against viruses.
Indeed, six human TLRs (TLR2, TLR3, TLR4, TLR7, TLR8 and TLR9)
and five murine TLRs (TLR2, TLR3, TLR4, TLR7 and TLR9) can
trigger the production of type-I IFN (interferon) that is central
to antiviral host defence (Zhang et al., 2007; Barbalat et al.,
2009). The activation of these TLRs also drives transcription of
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asnneuro.org / Volume 4 (4) / art:e00088 207various pro-inflammatory cytokines by innate immune cells;
this broadens the early host response to viral infection
and facilitates adaptive antiviral immunity, but it can
also accelerate tissue injury. Over the last decade, mice with
defects in these various nucleotide-sensing TLRs or their
downstream adaptor molecules have been shown to exhibit
diverse outcomes when challenged with different viral
pathogens (Akira et al., 2006; Zhang et al., 2007). Novel
intracellular TLRs (e.g. TLR13) that detect and respond to
viruses continue to be identified (Shi et al., 2011).
Recently, a point mutation of the ER protein, UNC93b1,
was found to ablate TLR3, TLR7 and TLR9 signalling in mice
(Tabeta et al., 2006; Brinkmann et al., 2007). Subsequent
studies showed that the mutant protein fails to transfer these
TLRs from the ER to their expected location in endosomes
(Kim et al., 2008). This 3d (triple defect) causes macrophages
from these mice to be profoundly impaired in their responses
to ligation of the nucleic acid-sensing TLRs as measured by
the production of multiple cytokines, including IFNa/b
(Tabeta et al., 2006; Brinkmann et al., 2007). Such
Unc93b1
3d/3d animals (herein referred to as UNC93b1-mutant
mice) proved highly susceptible to a systemic viral infection
that normal mice survived (Tabeta et al., 2006). Parallel
studies showed that humans with similar germline mutations
of Unc93b1 can have complete loss of UNC93b1 expression,
PBMCs (peripheral blood mononuclear cells) that do not
produce IFNa/b in response to TLR3, TLR7 or TLR9 ligands,
PBMCs with reduced IFNa/b production following exposure
to different viruses, and high lethality from HSE (herpes
simplex encephalitis) (Casrouge et al., 2006). Conversely,
these same individuals mount effective immune responses
against other viruses, verifying the presence of redundant
pathways that drive type-I IFN production previously shown
to exist in rodents (Casrouge et al., 2006).
Since the susceptibility of UNC93b1-mutant mice to CNS
(central nervous system) viral infection has not been well
studied, we challenged these animals with an NSV (neuroa-
dapted Sindbis virus) that causes a highly lethal encephalo-
myelitis. Titres of infectious virus, local inflammatory
responses and clinical disease outcomes were compared with
wild-type hosts. To characterize how CNS-derived myeloid
cells known to express the nucleotide-sensing TLRs respond to
NSV, primary microglia isolated from wild-type and
UNC93b1-mutant animals were exposed to virus or synthetic
TLR ligands in vitro. Our data show that multiple PRRs
(pattern recognition receptors) and downstream signalling
pathways, including but not limited to the endosomal TLRs,
drive the breadth of microglial cytokine and chemokine
production in response to NSV. Nonetheless, host survival
from infection appears largely independent of these TLR-
driven responses, even though it requires production of type-I
IFN to control CNS virus replication. Furthermore, the
heightened susceptibility of UNC93b1-mutant mice to NSV
infection is likely explained by a mechanism other than a
defect in endosomal TLR signalling, in large part because
redundant pathways driving type-I IFN production keep early
CNS virus replication in check. In this light, therapeutics
directed at these receptors and their signalling intermediates
for the treatment of acute alphavirus encephalitis in humans
must be carefully considered.
MATERIALS AND METHODS
Animals
Wild-type C57BL/6 mice and TLR3-deficient mice were
purchased from The Jackson Laboratory. C57BL/6-
Unc93b1
3d/3d mutant mice were obtained from the Mutant
Mouse Regional Resource Center at the University of
California. Mice rendered genetically deficient in the TLR
adaptor protein, MyD88 (myeloid differentiation response
gene 88) were a gift from Dr Steven Kunkel (University of
Michigan). IRF7 (IFN response factor 7)-deficient mice were a
gift from Dr Gabriel Nunez (University of Michigan). All
animals were bred, housed and used on-site under specific
pathogen-free conditions in strict accordance with guidelines
set by the National Institutes of Health and protocols
approved by the University Committee on the Use and Care
of Animals. Mice were housed on a 10 h light/14 h dark cycle
in ventilated cages containing not more than five animals per
cage. Food and water were available ad libitum.
Induction of experimental viral encephalitis and
other animal manipulations
To induce encephalomyelitis, 5–6-week-old mice were
anaesthetized with isoflurane (Abbott Laboratories) and
1000 pfu (plaque-forming units) of NSV suspended in 10 ml
of PBS were inoculated directly into the right cerebral
hemisphere of each animal. Some infected mice received
0.25 ml of clodronate liposomes intraperitoneally on days
1–5 post-infection to deplete circulating monocytes as
described (King et al., 2009). Clodronate liposomes and PBS
liposomes were both gifts from Roche Diagnostics. In other
infected cohorts, mice were injected with 0.5 mg of RB6
(anti-Gr-1) or a control IgG on days 1, 3 and 5 post-infection
to deplete circulating neutrophils as described (Carlson et al.,
2008; Daley et al., 2008). The RB6 and control IgG antibodies
were both gifts from Dr Benjamin Segal (University of
Michigan). Most cohorts of infected mice were monitored
daily for survival in accordance with approved animal
protocols. Some groups of animals were killed at defined
intervals post-infection to collect brain and spinal cord tissue
for further analysis. Following intra-cardiac perfusion with
ice-cold PBS, the left cerebral hemisphere and the lower half
of the spinal cord were isolated from some animals, snap-
frozen on dry ice and stored at 280˚C for virus titration
assays (see below). Remaining brain and spinal cord tissues
from these mice were frozen at 280˚C and used to generate
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PBS-perfused CNS tissue was used to isolated mononuclear
cells for flow cytometric analysis (see below).
Virus titration assays
Ten percent (w/v) homogenates of each tissue sample were
prepared in PBS, and serial 10-fold dilutions of each
homogenate were assayed for plaque formation on mono-
layers of BHK-21 cells, as previously described (Irani and
Prow, 2007). The results are presented as the geometric
means¡S.E.M. of the log10 number of pfu per gram of tissue
derived from a minimum of three animals at each time point.
Cytokine and chemokine assays
Frozen tissue samples were thawed, minced and homogenized in
0.5 ml of PBS containing a protease inhibitor cocktail and an
RNase inhibitor (Sigma–Aldrich). After homogenates were
centrifuged to pellet all remaining tissue debris, total protein
content was measured in each extract and supernatants were
diluted in PBS to a normalized total protein concentration.
Microglial culture supernatants were used undiluted in these
assays without further manipulation. Levels of individual
cytokines and chemokines were measured directly in samples
using commercial sandwich ELISA kits according to the
manufacturers’ instructions. The results for tissue samples reflect
the means¡S.E.M. of pg of chemokine/mg of tissue extracted
protein derived from a minimum of three animals at each time
point, while for culture supernatants reflect the means¡S.E.M.
pgofchemokine/mlofculturesupernatantderived fromtriplicate
cell culture wells. Quantification of TNFa (tumour necrosis factor
a), IL (interleukin)-12p40, and CCL (CC motif ligand) 2 levels was
performed using mouse OptEIA kits (BD Biosciences). IFNa,C C L 3 ,
CCL5 and CXCL13 (C-X-C motif ligand 13) levels were measured
using Duoset mouse ELISA kits (R&D Systems). The lower limit of
detection for all these assays was 5 pg/ml.
Analysis and separation of CNS-infiltrating
immune cell populations by flow cytometry
Perfused brains and/or spinal cords were minced into small
fragments and pressed through a 70-mM mesh sieve into
HBSS (Hanks balanced salt solution) containing 10% FBS
(fetal bovine serum) before digestion with collagenase
(0.2 mg/ml; Worthington Biochemicals) and DNase (28
units/ml; Sigma–Aldrich) for 40 min at 37˚C. Mononuclear
cells were then isolated over a 30%/70% Percoll gradient (GE
Healthcare Life Sciences) and washed with HBSS. All cells
were resuspended in PBS containing 2% FBS and stained with
fluorescently conjugated primary antibodies followed by flow
cytometric analysis on a FACSCanto II flow cytometer (BD
Biosciences). To quantify individual cell populations, cell
suspensions were stained with antibodies against CD3, CD4,
CD8, CD11b, CD45, Ly-6C and Ly-6G (all from eBioscience). A
minimum of 10000 events within a defined forward and side
scatter gate containing all CD45+ cells were analysed to
determine the proportion of each cell type in each
experimental sample. The total number of each cell
population present in individual brain or spinal cord speci-
mens was then calculated by multiplying the total number of
gradient-isolated cells from each sample (counted on a
haemocytometer) by the proportion of cells labelled with
each antibody. The results presented reflect the absolute
numbers of cells collected from a minimum of three animals
at each experimental time point. For intracellular cytokine
staining, CNS mononuclear cells were cultured for 5 h in
20 ng/ml phorbol myristate acetate, 1 mg/ml ionomycin and 5
mg/ml brefeldin A, fixed and permeabilized using a Cytofix/
Cytoperm kit (BD Biosciences), and stained with directly
conjugated anti-CD4, anti-IFN-c and anti-IL-17 antibodies
(eBiosciences). For cell sorting, CNS myeloid cells were stained
with a combination of CD45 and CD11b, and then separated
into CD45
low/CD11b+ and CD45
high/CD11b+ populations
using a MoFlo XDP High-Speed Cell Sorter (Beckman-
Coulter). Individual cell populations pooled from 10 animals
were stored at 220˚C in PrepProtect RNA stabilization
solution (Miltenyi Biotec) until RNA isolation was performed.
qPCR (quantitative PCR) analysis of type-I IFN
expression by distinct CNS-derived mononuclear
cell populations
Lysates of flow sorted myeloid cell populations were thawed
and carefully removed from the PrepProtect solution. Total
RNA was isolated from CD45
low/CD11b+ cells and CD45
high/
CD11b+ cells pooled from the brains of ten naı ¨ve or NSV-
infected mice using QIAshredder Kit and the RNeasy Mini Kit
according to the manufacturer’s instructions (Qiagen). cDNA
was then generated using the SuperScriptH III First Strand
Synthesis System for reverse transcriptase–PCR (Invitrogen).
qPCR was undertaken to measure ifnb1 mRNA transcripts
using the MyiQ Single Color Real-Time PCR Detection System
(Bio-Rad) and the ifnb1 primer/probe set in the TaqManH
Gene Expression Assay (Applied Biosystems). Data were
analysed using the D/DCt calculation, and the ifnb1 results
were normalized to the D/DCt values for b-actin mRNA.
Preparation and use of primary microglial
cultures
Primary microglia were isolated and cultured from the
cortices of 2–3-day-old mice as described (Esen and Kielian,
2005). When mixed glial cultures reached confluency after 7–
10 days, flasks were shaken overnight at 200 rev./min at 37˚C
to detach microglia from the more firmly adherent astro-
cytes. Cells in suspension (.95% pure CD11b+ microglia)
were collected and 1610
5 cells plated into each well of 96-
well plates. The next day, microglia were stimulated for 24 h
either with NSV or a known TLR ligand in a total volume
of 200 ml as follows: 1610
6 pfu NSV (infectious virus
Alphavirus-induced microglial activation
E 2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
209particle-to-cell ratio of 10:1), 100 ng/ml Escherichia coli LPS
(lipopolysaccharide) (List Biological Laboratories) (a TLR4
stimulus), 25 mg/ml poly(I:C) (polyinosinic:polycytidylic acid;
Invivogen) (a TLR3 stimulus), 1 mM loxoribine (Invivogen) (a
TLR7 stimulus) or 3 mM unmethylated DNA ODNs (oligodeox-
ynucleotides) bearing CpG motifs (CpG-ODN) (Invivogen) (a
TLR9 stimulus). Some experiments were conducted in the
presence of 20 nM of Baf A1 (bafilomycin A1) (Sigma–
Aldrich) to prevent the acidification of endosomes and thus
blocking virus uncoating by inhibiting acid-induced fusion
of viral envelopes and the endosomal membrane (Jan and
Griffin, 1999). Pilot studies were performed using UV light-
inactivated NSV generated by exposing the virus to a
germicidal lamp (wavelength5254 nm) at a distance of
5c m f o r 1h a t 4 ˚C. Heat inactivation of NSV was
accomplished by maintaining the pathogen at 60˚C for
15 min before use. Inactivation of viral infectivity was
confirmed via the plaque titration assay described above. At
the end of the 24-h microglial treatment period, culture
supernatants were collected and stored at 280˚C until
cytokine and chemokine analyses could be performed by
ELISA assays. Microglial viability was assayed using well-
established MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
2H-tetrazolium bromide] assay.
Statistical analysis
The Prism 5.0 software package (GraphPad Software) was used
for all statistical analyses. Differences in survival among
cohorts of mice were measured using a log-rank (Mantel-Cox)
test. Unpaired Student’s t test was used to assess differences
between different experimental groups at single time points. A
two-way ANOVA test was applied when comparing different
experimental groups over time. In all cases, differences at a
P,0.05 level were considered significant.
RESULTS
Effects of UNC93b1 mutation on the course of
NSV encephalitis in mice
Humans with germline Unc93b1 mutations were found to
exhibit endosomal TLR signalling defects and have high
susceptibility to HSE even as they mounted more normal
immune responses against other viruses (Casrouge et al.,
2006). To further investigate how the UNC93b1 protein
affects CNS viral pathogenesis, wild-type and UNC93b1-
mutant mice were challenged with NSV, a neuroadapted
member of the alphavirus family that causes lethal
encephalomyelitis in rodents and is closely akin to the
neurotropic alphaviruses that infect humans. Outcome in this
model is highly dependent on an effective type-I IFN response
to control early CNS virus replication (Byrnes et al., 2000;
Ryman et al., 2000). In vivo challenge experiments showed
that UNC93b1-mutant animals were very susceptible to
infection, with significantly accelerated death compared with
wild-type controls (Figure 1A). Surprisingly, however, this
poorer outcome was not explained by impaired type-I IFN
production in the CNS (Figures 1B and 1C), or by excessive
virus replication in target tissues (Figures 1D and 1E). Thus,
the wild-type UNC93b1 protein must regulate some host
response that protects mice from NSV encephalitis via a
mechanism other than one either directly targeting the
pathogen itself or the main antiviral immune effector.
CNS host responses in wild-type and UNC93b1-
mutant mice during NSV encephalitis
To investigate the effects of UNC93b1 mutation on CNS host
responses elicited during NSV encephalitis, brain and spinal
cord leucocytes were characterized by flow cytometry.
Quantification of T-cells and myeloid cells was emphasized,
since these populations constitute the bulk of the parenchy-
mal infiltrate elicited during infection (Moench and Griffin,
1984; Irani and Griffin, 1990). The total number of CD45+
leucocytes isolated from the CNS of infected animals was
similar between UNC93b1-mutant mice and wild-type
controls (Figure 2A). Tissue-infiltrating CD3+ T-cells were
also found in comparable numbers between the two hosts
(Figure 2B), and CD4+ and CD8+ T-cell subsets occurred in
equal proportions (data not shown). Within the CD4+ T-cell
population, cells capable of making IFNc or IL-17 were
detected with equivalent frequencies (data not shown). These
data would seem to exclude a role for UNC93b1 in T-helper
cell differentiation in this disease model. Conversely, fewer
CD11b+ myeloid cells were isolated from both the brains and
spinal cords of UNC93b1-mutant animals at later stages of
NSV infection (Figure 2C). These CD11b+ cells were both
CD45
high, likely infiltrating monocytes and neutrophils or
highly activated microglia, as well as CD45
low, likely microglia
in a more quiescent state (Figure 2D). Separation of these
discrete CD11b+ populations via flow sorting followed by
analysis of the mRNA content via qPCR of cells pooled from
multiple animals revealed that both CD45
low and CD45
high
cells were important sources of type-I IFN in the CNS during
the early stages of infection (Figure 2E). The observed
differences in CD11b+ cell numbers found in the CNS
suggest that the accelerated mortality seen in UNC93b1-
mutant mice could be due to impaired recruitment of a
protective myeloid cell population from the periphery.
Alternatively, the local tissue microglial response to infection
could differ in some way other than type-I IFN production
that influences overall host survival.
Effects of CD11b+ monocyte or neutrophil
depletion during NSV encephalitis
Since higher numbers of CNS myeloid cells were asso-
ciated with the improved outcome of wild-type versus
N. Esen and others
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performed to investigate whether two distinct CD45
high/
CD11b+ cell types normally present in circulation might enter
the CNS during NSV encephalitis to facilitate host survival.
In the first approach, wild-type animals were infected with
NSV and then treated with clodronate-loaded liposomes that
get phagocytosed by circulating monocytes, causing their
apoptotic destruction (King et al., 2009). Flow cytometry
demonstrated that CD45
high/CD11b+ monocytes had largely
been eliminated from the CNS of clodronate liposome-treated
animals compared with controls that received PBS liposomes
on day 6 post-infection (Figures 3A and 3B). Likewise, Ly-6C+
monocytes were virtually undetectable in the blood of these
animals 24 h after their last clodronate liposome treatment
(data not shown). Nonetheless, the two cohorts of animals
showed no difference in overall disease survival (Figure 3C). In
the second set of experiments, wild-type mice were treated
with the monoclonal antibody, RB6, used to deplete circulating
Gr-1+ neutrophils in vivo (Carlson et al., 2008; Daley et al.,
2008). Treatment was highly effective in eliminating the
desired population from the CNS on day 6 post-infection
compared with animals given a control antibody (Figures 4A
and 4B), but depletion of these cells also had no effect on
disease outcome (Figure 4C). Anti-RB6-treated mice had
almost no Ly-6G+ cells present in circulation at the same time
that CNS tissues were collected (data not shown). These data
exclude the involvement of the two main circulating CD45
high/
CD11b+ cell populations in NSV pathogenesis. By extension,
they suggest that wild-type UNC93b1 may act through an
endogenous CNS cell-type to slow disease progression.
Figure 1 Mutation of the ER protein, UNC93b1, alters the pathogenesis of NSV encephalitis in mice
UNC93b1-mutant animals are more susceptible to fatal NSV infection than wild-type controls (n520 mice per group) (A). This
heightened disease susceptibility is not associated with altered type-I IFN levels in the brain or spinal cord as measured by ELISA
(B, C), nor is it due to unrestrained viral replication in either tissue compartment as determined by plaque assay (D, E). Type-I IFN
levels and viral titres in these experiments were measured in triplicate CNS samples collected at each time point from a single cohort
of mice.
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211Cytokine and chemokine responses generated by
UNC93b1-mutant microglia in vitro
As microglia express multiple TLRs and become activated early
during NSV encephalitis (Irani and Prow, 2007; Prow and
Irani, 2007), primary cultures of these cells were prepared
from wild-type and UNC93b1-mutant animals for in vitro
study. When directly exposed to NSV at an infectious particle-
to-cell ratio of 10:1, primary microglia did not become
productively infected or show any loss of cell viability over a
24-h culture interval (data not shown). Still, both NSV and
various synthetic TLR ligands triggered a broad range of
inflammatory mediators in wild-type cells. This included
production of a subset of pro-inflammatory cytokines
(Figures 5A and 5B), type-I IFN (Figure 5C) and multiple
chemokines (Figure 6). Since many of these mediators are
induced in the CNS during NSV encephalitis in vivo
(Wesselingh et al., 1994; Irani and Prow, 2007), microglia
may be important early integrators of the host response to
infection.
Figure 2 Analysis of CNS infiltrates in wild-type and UNC93b1-mutant mice during NSV encephalitis by flow cytometry and qPCR
Although the total numbers of CD45+ leucocytes (A) and CD3+ T-cells (B) present in brain and spinal cord are comparable between
these two hosts during NSV infection, fewer CD11b+ myeloid cells accumulate at both CNS sites over time in UNC93b1-mutant mice
(C). Tissue cell numbers were determined as described in Materials and Methods section in a single cohort of mice using samples
collected from three animals at each time point. By flow cytometry, these CD11b+ cells in the brains of wild-type mice on day 6
post-infection include both CD45
high and CD45
low populations (D). Flow sorting of these individual cell populations pooled from
brains of naı ¨ve or day 3 post-infection mice shows that both CD45
low/CD11b+ and CD45
high/CD11b+ cells contain type-I IFN mRNA
by qPCR analysis (E). This assay was performed once using cells pooled from 10 naı ¨ve or 10 NSV-infected mice as source material for
total cellular RNA extraction.
N. Esen and others
212 E 2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.To better understand whether the endosomal TLRs
contribute to microglial activation following exposure to
NSV, cells derived from UNC93b1-mutant mice were
compared with those from wild-type hosts. These assays
showed that pro-inflammatory cytokine responses were
ablated in mutant cells following stimulation with NSV or
synthetic TLR3, TLR7 or TLR9 ligands (Figures 5A and 5B), as
Figure 3 Effects of monocyte depletion on the course of NSV encephalitis
in wild-type mice
Treatment with clodronate-loaded liposomes effectively prevents CNS
infiltration of CD45
high circulating monocytes on day 6 of NSV encephalitis
compared with PBS-loaded liposomes (A, B). Dot plots show staining when
gated on CD11b+ cells only. Systemic depletion of these cells has no effect
on the outcome of NSV encephalitis (C). Data are representative of two
separate experiments performed under identical conditions.
Figure 4 Effects of neutrophil depletion on the course of NSV encephalitis
in wild-type mice
RB6 antibody (anti-Gr-1) treatment effectively prevents CNS infiltration of
Ly-6G+ circulating neutrophils on day 6 of NSV encephalitis compared with a
control IgG (A, B). Dot plots show staining when gated on CD45
high/CD11b+
cells only. Systemic depletion of these cells has no effect on the outcome of
NSV encephalitis (C). Data are representative of two separate experiments
performed under identical conditions.
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213were the chemokine responses triggered by TLR7 or TLR9
ligands (Figure 6). LPS, a TLR4 ligand that acts at the cell
surface rather than in endosomes, stimulated equivalent
production of all mediators in both cell types (Figures 5 and
6). IFNa and various CC chemokine ligands were also
generated at similar levels by cells of both genotypes in
response to NSV or poly(I:C) (Figures 5C, 6A and 6C),
although virus-induced production of CXCL13 was signifi-
cantly reduced in mutant versus wild-type cells (Figure 6D).
In addition to being a known TLR3 ligand, poly(I:C) also
triggers the cytoplasmic RNA sensor, MDA5 (melanoma-
differentiation-associated gene 5) (Kato et al., 2006). The
activation of this pathway could explain why both poly(I:C)
and NSV still provoked certain responses in UNC93b1-mutant
cells. Nonetheless, these data show that NSV induces the
production of a broad range of inflammatory mediators by
primary microglia and that such responses are activated
through non-overlapping pathways, only some of which are
triggered by the endosomal TLRs.
Viral determinants that activate microglial
cytokine and chemokine production
Pilot assays showed that NSV particles exposed to heat or UV
light did not trigger microglial cytokine or chemokine
production (data not shown). This suggests that damage to
the viral genome prevents its recognition by these cells.
At the onset of the alphavirus replication cycle, receptor-
mediated endocytosis brings the virus into early endosomes
where exposure to an acidic pH induces conformational changes
that allow fusion of the viral envelope with the endosomal
membrane and delivery of the single-stranded viral RNA
genome into the cytoplasm (Strauss and Strauss, 1994). Since
neurons can detect and respond to NSV at the time of cell entry
(Jan and Griffin, 1999), we tested whether blockade of viral
fusion had any effect on microglial cytokine and chemokine
production. Baf A1, a selective inhibitor of the vacuolar proton-
ATPase (Drose and Altendorf, 1997), blocks endosomal acidifica-
tion and prevents NSV from uncoating in neuronal cells (Jan and
Griffin, 1999). We found that wild-type microglia pretreated for
30 min with 20 nM Baf A1 prior to virus exposure were
significantly impaired in their capacity to generate IL-12p40,
IFNa and several CC chemokine ligands compared with
untreated control cells (Figure 7). Drug treatment had no effect
on cell viability or on the capacity of microglia to trigger IFNa
production in response to poly(I:C) (data not shown). We
conclude that NSV must uncoat itself in primary microglia in
order to trigger innate immune signalling. This suggests that
intact viral nucleic acids, rather than viral envelope glycopro-
teins, are the main stimuli that activate these cells.
Unfortunately, any subsequent requirement for endosomal
versus cytosolic signalling pathways cannot be inferred from
these data since all events downstream of virus entry are
blocked in Baf A1-treated cells.
Downstream signalling intermediates involved in
the microglial response to NSV
To further understand how various microglial PRRs signal in
response to NSV, cells derived from other mutant animals
were examined. All TLR signalling pathways except ones
downstream of TLR3 converge on the common intracellular
adaptor protein, MyD88 (Akira and Takeda, 2004). Both the
TLRs and the cytoplasmic RLRs (retinoic acid-inducible gene
I-like receptors) also activate the IRFs, particularly IRF3 and
Figure 5 In vitro cytokine production by primary microglia cultures
derived from either wild-type or UNC93b1-mutant mice
Cultures were prepared as outlined in Materials and Methods section. Three
wells were left untreated, exposed to NSV or stimulated with synthetic
ligands for the TLRs indicated also as described in Materials and Methods
section. Cytokine concentrations were measured in culture supernatants 24 h
later using ELISA-specific for IL-12p40 (A), TNFa (B) and IFN-a (C). The
production of these mediators was measured using primary cells prepared on
two separate occasions.
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Cultures were prepared as outlined in Materials and Methods section. Three wells were left untreated, exposed to NSV or stimulated
with synthetic ligands for the TLRs indicated also as described in Materials and Methods section. Chemokine concentrations were
measured in culture supernatants 24 h later using ELISA-specific for CCL2 (A), CCL3 (B), CCL5 (C) and CXCL13 (D). The production of
these mediators was measured using primary cells prepared on two separate occasions.
Figure 7 Effects of Baf A1, a pharmacological inhibitor of virus uncoating in endosomes, on cytokine and chemokine production by
primary microglia cultures prepared from wild-type mice and then exposed to NSV
Some wells were treated with Baf A1 as outlined in Materials and Methods section. A minimum of three wells either without or with
Baf A1 pretreatment were then exposed to NSV, and cytokine and chemokine concentrations measured by ELISA in culture
supernatants 24 h later using ELISA-specific for IL-12p40 (A), IFN-a (B), CCL2 (C) and CCL5 (D). The production of these mediators
without or with Baf A1 treatment was measured using primary cells prepared on two separate occasions.
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215IRF7, to drive the release of type-I IFN (Genin et al., 2009). We
found that virus-induced production of IL-12p40 was fully
ablated in primary microglia derived from MyD88-deficient
hosts (Figure 8A). Since this defect was also observed in
UNC93b1-mutant cells (Figure 5A), it is likely that TLR7 and/or
TLR9 signalling stimulate release of this particular mediator in
response to NSV. The production of IFNa, on the other hand,
depended entirely on IRF7 activation (Figure 8B), which could
be induced via upstream TLR3 and/or RLR activation. However,
because TLR3-deficient cells generated significant levels of
IFNa in response to both NSV and poly(I:C) (Figure 8C),
cytoplasmic RLR pathways such as those triggered by MDA5
are presumably involved. Virus-induced production of CCL2 by
microglia was partially MyD88-dependent (Figure 8D). Since
itsreleasewasunaffectedinUNC93b1-mutantcellsexposedto
NSV (Figure 6A), signals delivered by a non-endosomal TLR as
well as some non-TLR pathway must both be involved in the
induction of this mediator. Finally, NSV actually triggered
augmented production of CXCL13 in the absence of IRF7
(Figure 8E), suggesting that type-I IFN might negatively
regulate this chemokine. Overall, these data confirm that
multiple PRRs and downstream signalling pathways drive the
breadth of cytokine and chemokine production by primary
microglia in response to NSV (Table 1).
Impact of specific PRR signalling defects on the
outcome of NSV encephalitis
Given both the redundancy and breadth of virus-induced PRR
activation in cultured microglial cells, involvement of these
signalling intermediates during NSV encephalitis was exam-
ined in vivo. As was observed in UNC93b1-mutant mice
(Figure 1A), IRF7-deficient animals were highly susceptible to
fatal NSV infection (Figure 9A). In this case, however, CNS
virus replication was poorly controlled; upwards of 100-fold
more infectious NSV was found in the brains and spinal cords
of mutants compared with wild-type animals (Figures 9B
and 9C). These IRF7-deficient mice failed to generate any
measurable amount of type-I IFN in the CNS over the course
of infection (data not shown). In contrast, the survival of
both MyD88- and TLR3-deficient mice was not significantly
different from wild-type controls (Figures 9D and 9E), and
neither of these mutant hosts showed any defect in type-I
IFN production within the CNS over the course of NSV
infection (Figure 9F). These findings reinforce the importance
of type-I IFN for the control of NSV replication and host
survival, as previously reported during infections caused by
less virulent viral strains (Byrnes et al., 2000). Although it is
possible that TLR3- and MyD88-dependent responses fully
compensate for one another during NSV infection, our in
vitro data strongly implicate the actions of a non-TLR-
dependent pathway in the type-I IFN response (Figures 5C
and 8C). This suggests that TLR-dependent responses do not
contribute to disease outcome, and by extension, that the
wild-type UNC93b1 protein confers protection via some
mechanism independent of endosomal TLR signalling.
DISCUSSION
Alphaviruses infect neurons of the brain and spinal cord,
and neuronal survival controls in vivo outcome in acute
encephalitis models (Lewis et al., 1996; Kerr et al., 2002). Not
only can these pathogens directly kill the target cells they
infect, but they also provoke substantial bystander damage to
uninfected neurons (Havert et al., 2000; Nargi-Aizenman
et al., 2004; Prow and Irani, 2008). Indeed, blockade of this
bystander neuronal damage greatly reduces NSV-induced
mortality without affecting CNS viral replication or clearance
(Nargi-Aizenman et al., 2004; Irani and Prow, 2007; Prow and
Irani, 2007; 2008). Current data suggest that innate host
responses arising from activated microglia trigger changes in
adjacent astrocytes that drive this bystander neuronal injury
(Darman et al., 2004; Irani and Prow, 2007; Prow and Irani,
2007, 2008; Carmen et al., 2009). Blockade of the type-I IFN
response, however, causes unrestrained CNS virus replication
early in disease that is rapidly lethal to the host (Byrnes et al.,
2000). Thus, early activation of innate immunity is crucial in
alphavirus pathogenesis. We sought to identify the signalling
receptors triggering microglial production of type-I IFN
and other inflammatory mediators that influence disease
outcome. Our data show that NSV activates microglia via
multiple PRRs, that these cells are an important source
of type-I IFN in the CNS during early stages of disease, that
type-I IFN production occurs independent of TLR signalling
and that the ER protein, UNC93b1, plays an unexpected and
still poorly understood protective role during infection.
Although other investigators have shown that RNA viruses
can trigger microglia to produce inflammatory cytokines
(Olson and Miller, 2004), our studies reveal a previously
unreported breadth and complexity of this response. Not only
do microglia make a wide range of cytokines and chemokines
following exposure to NSV, but it is clear that such responses
are driven by non-overlapping signalling pathways activated
by multiple PRRs (Table 1). UNC93b1 and MyD88 are both
required for generating certain pro-inflammatory cytokines
such as IL-12p40 (Figures 5A and 8A), meaning that an
endosomal pathway utilizing TLR7 and/or TLR9 is involved.
The CC ligand chemokine responses, on the other hand, occur
independently of UNC93b1 and are only partially dependent
on MyD88 (Figures 6A–6C and 8D), demonstrating that signals
delivered by a non-endosomal TLR and some non-TLR pathways
are both required. Like IL-12p40, production of CXCL13 by
microglia depends on both UNC93b1 and MyD88 (Figures 6D
and 8E), but this chemokine is also negatively regulated via an
IRF7-dependent mechanism (Figure 8E). Most importantly,
production of type-I IFN absolutely requires IRF7 and is not
activated by any of the classical endosomal TLRs (Figures 5C,
8B and 8C). This complexity presents opportunities to subvert
an individual pathway for therapeutic purposes during
infection. In particular, interventions that target the pro-
inflammatory cascades resulting in bystander neuronal injury
might be feasible without disrupting the type-I IFN response.
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production in the CNS during SV (Sindbis virus) encephalitis
has remained poorly understood. IFNa/b receptor null mice
are highly susceptible to a number of viruses, including the
mosquito-borne alphaviruses (Muller et al., 1994; Huang
et al., 1995; Grieder and Vogel, 1999). Replication of wild-
type SV is strongly inhibited by IFNa in vitro (Depres et al.,
1996), and SV encephalitis generates large amounts of type-I
IFN within the CNS in vivo (Vilcek, 1964; Sherman and Griffin,
1990). Mice deficient in the IFNa/b receptor rapidly succumb
to attenuated strains of SV; direct intracerebral inoculation
results in uncontrolled CNS virus replication and death that
normal mice survive (Byrnes et al., 2000), while systemic
challenge causes fatal disease with expanded tissue tropism
and high peripheral and CNS tissue viral titres not seen in
receptor-sufficient hosts (Byrnes et al., 2000; Ryman et al.,
2000). Our data show that for the virulent NSV strain, the
type-I IFN response within the CNS is triggered via TLR-
independent pathways (Figures 8B, 8C and 9F). Furthermore,
early type-I IFN production arises from both microglia and
infiltrating myeloid cells (Figure 2E), and is highly IRF7-
dependent (Figure 8B and data not shown). Mice incapable of
making type-I IFN have high lethality and uncontrolled CNS
virus replication following NSV challenge (Figures 9A–9C).
Figure 8 In vitro chemokine production by primary microglia cultures derived from either wild-type, MyD88-, IRF7- or TLR3-deficient
mice following exposure to either NSV (A, B, D, E) or NSV or poly(I:C) (C)
Cultures were prepared as outlined in Materials and Methods section. A minimum of three wells were exposed to NSV or poly(I:C) as
described in Materials and Methods section. Cytokine and chemokine concentrations were measured by ELISA in culture supernatants
24 h later using ELISA-specific for IL-12p40 (A), IFN-a (B, C), CCL2 (D) and CXCL13 (E). The production of these mediators was
measured using primary cells prepared on two separate occasions.
Table 1 NSV triggers the production of inflammatory mediators in primary microglia via multiple non-overlapping signalling pathways
Mediator UNC93b1-dependent MyD88-dependent IRF7-dependent
IL-12p40 ++2
CCL2 2 +/22
CXCL13 +++ *
IFNa 22+
* Inhibitory.
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217Since expression of IRF7 is restricted to haematopoietic cells
and can be induced by various external stimuli (Ning et al.,
2011), it is possible that the early type-I IFN response could
be augmented by manipulating IRF7 levels. Our findings shed
important light on this critical antiviral host defence pathway
during alphavirus encephalitis.
Because of their capacity to detect common DNA and RNA
replication intermediates of many viral pathogens, the
endosomal TLRs are considered central to innate host defence
against viral infections. Recently, a point mutation of the ER
chaperone protein, UNC93b1, was found to ablate TLR3, TLR7
and TLR9 signalling in mice because the mutant protein fails
to transfer the receptors from the ER to their natural location
in endosomes (Tabeta et al., 2006; Brinkmann et al., 2007;
Kim et al., 2008). Macrophages from these mice have
profoundly impaired cytokine responses, including type-I
IFN production, when exposed to synthetic ligands that
activate the endosomal TLRs (Tabeta et al., 2006; Brinkmann
et al., 2007). Such animals are also highly susceptible to viral
pathogens such as murine CMV (cytomegalovirus) due to
uncontrolled systemic virus replication (Tabeta et al., 2006).
Together, these data suggested that UNC93b1-mutant mice
should be highly susceptible to NSV challenge because of
their impaired host response to infection. Although enhanced
disease susceptibility proved to be true, mutant animals
mounted a surprisingly normal type-I IFN response and fully
controlled NSV replication in the CNS (Figure 1). We have not
yet identified a mechanism through which the wild-type
UNC93b1 protein prolongs survival in this disease. Looking at
other models, however, animals carrying this mutation have a
Figure 9 Pathogenesis of NSV encephalitis in IRF7-, MyD88- and TLR3-deficient mice
IRF7-deficient mice are highly susceptible to fatal NSV infection compared with wild-type controls (n510 per group) (A). This
heightened disease susceptibility is associated with unrestrained viral replication in the brain (B, P50.0009 by two-way ANOVA) and
spinal cord (C, P50.0002 by two-way ANOVA). Neither MyD88- nor TLR3-deficient mice show altered disease susceptibility
compared with wild-type controls (n512 per group) (D, E). Both MyD88- and TLR3-deficient hosts generate equivalent levels of
type-I IFN in the CNS over the course of infection compared with wild-type controls (F).
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impaired CNS type-I IFN response or altered virus replication
in the brain (Wang et al., 2011). On the other hand,
UNC93b1-mutant mice were recently found to have
unrestrained parasite replication during experimental
Toxoplasma gondii infection fully independent of their TLR
signalling defects (Melo et al., 2010). These data, in
conjunction with our findings, reveal that this chaperone
protein serves some critical TLR-independent function in the
setting of intracellular infection.
Another notable result among the data reported here is the
apparent role of IRF7 in dampening microglial production of
the lymphoid chemokine, CXCL13 (Figure 8E). This finding
suggests that type-I IFNs act in either an autocrine or
paracrine manner to negatively regulate the generation of
this mediator within the CNS. Under normal circumstances
CXCL13 helps form germinal centres in lymphoid organs
(Forster et al., 1996; Legler et al., 1998; Bagaeva et al., 2006),
but its ectopic expression has been reported around B-cell
aggregates that develop in the inflamed meninges of mice
with EAE (experimental autoimmune encephalomyelitis) and
humans with multiple sclerosis (Magliozzi et al., 2004, 2007;
Serafini et al., 2004; Aloisi et al., 2008; Lalor and Segal, 2010).
Perivascular mononuclear cells and parenchymal microglia
within active multiple sclerosis plaques also express CXCL13
(Krumbholz et al., 2006), and cerebrospinal fluid levels of the
protein are elevated in samples from patients with the RRMS
(relapsing-remitting form of multiple sclerosis) and decline
with successful therapy (Sellebjerg et al., 2009; Piccio et al.,
2010; Khademi et al., 2011; Ragheb et al., 2011). The
production of CXCL13 is pathogenic during EAE by sustaining
myelin-specific CD4+ T-cell responses, and in vivo neutral-
ization of CXCL13 ameliorates disease (Bagaeva et al., 2006).
Since subcutaneous or intramuscular administration of IFNb
has been convincingly shown to reduce relapse rate, disability
progression and the formation of new brain and spinal cord
lesions in patients with RRMS (The IFNB Multiple Sclerosis
Study Group, 1993; UBC MS/MRI Study Group and The IFNB
Multiple Sclerosis Study Group, 1993; The Multiple Sclerosis
Collaborative Research Group, 1996; Prevention of Relapses
and Disability by IFNb1a Subcutaneously in Multiple Sclerosis
Study Group, 1998; The Multiple Sclerosis Collaborative
Research Group, 1998), its capacity to regulate CXCL13
production may be an explanation for its mechanism of
action in this complex neuroinflammatory disease. Further
studies are underway to address this important question.
In summary, data presented here show that microglial
activation in response to a neurotropic alphavirus is a
complex process involving multiple, non-overlapping PRRs.
Although endosomal TLR, non-endosomal TLR and non-TLR
pathways all contribute to virus-induced cytokine and
chemokine production by these cells, the type-I IFN response
is activated in a TLR-independent manner. Microglia are an
important source of type-I IFNs within the CNS during the
initial stages of infection, and this response is critical for both
early control of virus replication within the target tissue and
subsequent host survival. Recent studies show that activated
microglia trigger a cascade of cellular events, including
disruption of the homoeostatic support provided by astro-
cytes that augment neuronal injury during NSV encephalo-
myelitis (Darman et al., 2004; Irani and Prow, 2007; Prow and
Irani, 2007, 2008; Carmen et al., 2009). Being able to
selectively target such pro-inflammatory mediators by means
of disrupting the receptors and pathways that activate them,
without impacting the type-I IFN response, raises hope that
more precisely targeted immunotherapies can be developed
for these life threatening human infections.
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